Substance or medication-induced depressive disorder: Difference between revisions
Kiran Singh (talk | contribs) No edit summary |
Rohit reddy (talk | contribs) |
||
(18 intermediate revisions by 4 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Clinical depression}} | ||
{{CMG}} {{AE}} {{KS}} | {{CMG}}; {{AE}} {{KS}} | ||
==Overview== | ==Overview== | ||
Substance-induced depressive disorder is characterized by a persistent depressed mood that developed during or after substance intoxication or withdrawal or after exposure to a medication. | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Substance- or medication-induced depression must be differentiated from: | |||
*[[Depressive disorder]] due to another medical condition | *[[Depressive disorder]] due to another medical condition | ||
*Primary [[depressive disorder]] | *Primary [[depressive disorder]] | ||
Line 14: | Line 16: | ||
==Risk Factors== | ==Risk Factors== | ||
Risk factors for the development of substance- or medication-induced depressive disorder include: | |||
*[[Antisocial behavior]] | *[[Antisocial behavior]] | ||
*[[Alcohol]] or drug use disorders | *[[Alcohol]] or drug use disorders | ||
*Family history of substance use disorders | |||
*History of drug induced [[depression]] | *History of drug induced [[depression]] | ||
*History of stressful life events | *History of stressful life events | ||
*[[ | *History of [[major depressive disorder]] | ||
*Psychosocial stressors | *Psychosocial stressors | ||
*Specific type of medication<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | *Specific type of medication | ||
:*Effavirenz | |||
:*High [[estrogen]]/[[Progesterone]] in OCP | |||
:*[[Interferon alpha]] | |||
:*[[Prednisone]]<ref name=DSMV>{{cite book | title = Diagnostic and statistical manual of mental disorders : DSM-5 | publisher = American Psychiatric Association | location = Washington, D.C | year = 2013 | isbn = 0890425558 }}</ref> | |||
==Diagnostic Criteria== | ==Diagnostic Criteria== | ||
Line 27: | Line 34: | ||
{{cquote| | {{cquote| | ||
*A.A prominent and persistent disturbance in mood that predominates in the clinical picture and is characterized by [[Clinical depression|depressed mood]] or markedly diminished interest or pleasure in all, or almost all, activities. | *A. A prominent and persistent disturbance in mood that predominates in the clinical picture and is characterized by [[Clinical depression|depressed mood]] or markedly diminished interest or pleasure in all, or almost all, activities. | ||
'''''AND''''' | '''''AND''''' | ||
*B.There is evidence from the history, physical examination, or laboratory findings of both (1)and(2): | *B. There is evidence from the history, physical examination, or laboratory findings of both (1) and (2): | ||
:*1.The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication. | :*1. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication. | ||
:*2.The involved substance/medication is capable of producing the symptoms in Criterion A. | :*2. The involved substance/medication is capable of producing the symptoms in Criterion A. | ||
'''''AND''''' | '''''AND''''' | ||
*C.The disturbance is not better explained by a [[depressive disorder]] that is not substance/medication-induced. Such evidence of an independent [[depressive disorder]] could include the following: | *C. The disturbance is not better explained by a [[depressive disorder]] that is not substance/medication-induced. Such evidence of an independent [[depressive disorder]] could include the following: | ||
:*The symptoms preceded the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute | :* The symptoms preceded the onset of the substance/medication use; the symptoms persist for a substantial period of time (e.g., about 1 month) after the cessation of acute withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced [[depressive disorder]] (e.g., a history of recurrent non-substance/medication-related episodes). | ||
withdrawal or severe intoxication; or there is other evidence suggesting the existence of an independent non-substance/medication-induced depressive disorder (e.g., a history of recurrent non-substance/medication-related episodes). | |||
'''''AND''''' | '''''AND''''' | ||
*D.The disturbance does not occur exclusively during the course of a [[delirium]]. | *D. The disturbance does not occur exclusively during the course of a [[delirium]]. | ||
'''''AND''''' | '''''AND''''' | ||
*E.The disturbance causes clinically significant distress or impairment in social, occupational,or other important areas of functioning. | *E. The disturbance causes clinically significant distress or impairment in social, occupational,or other important areas of functioning. | ||
<SMALL>''Note:This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when they are sufficiently severe to warrant clinical attention | <SMALL>''Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when they are sufficiently severe to warrant clinical attention.''</SMALL> | ||
}} | }} | ||
Latest revision as of 19:30, 23 August 2021
Clinical Depression Microchapters |
Diagnosis |
---|
Treatment |
Follow-up |
Case Studies |
Substance or medication-induced depressive disorder On the Web |
American Roentgen Ray Society Images of Substance or medication-induced depressive disorder |
Substance or medication-induced depressive disorder in the news |
Blogs on Substance or medication-induced depressive disorder |
Risk calculators and risk factors for Substance or medication-induced depressive disorder |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Overview
Substance-induced depressive disorder is characterized by a persistent depressed mood that developed during or after substance intoxication or withdrawal or after exposure to a medication.
Differential Diagnosis
Substance- or medication-induced depression must be differentiated from:
- Depressive disorder due to another medical condition
- Primary depressive disorder
- Substance intoxication and withdrawal[1]
Epidemiology and Demographics
Prevalence
The prevalence of substance or medication-induced depressive disorder is 260 per 100,000 (0.26%) of the overall population.[1]
Risk Factors
Risk factors for the development of substance- or medication-induced depressive disorder include:
- Antisocial behavior
- Alcohol or drug use disorders
- Family history of substance use disorders
- History of drug induced depression
- History of stressful life events
- History of major depressive disorder
- Psychosocial stressors
- Specific type of medication
- Effavirenz
- High estrogen/Progesterone in OCP
- Interferon alpha
- Prednisone[1]
Diagnostic Criteria
DSM-V Diagnostic Criteria for Substance/Medication-Induced Depressive Disorder [1]
“ |
AND
AND
AND
AND
Note: This diagnosis should be made instead of a diagnosis of substance intoxication or substance withdrawal only when the symptoms in Criterion A predominate in the clinical picture and when they are sufficiently severe to warrant clinical attention. |
” |